Molecure S.A. Logo

Molecure S.A.

MOC | WAR

Overview

Corporate Details

ISIN(s):
PLONCTH00011
LEI:
2594003L11V38ZCVKZ09
Country:
Poland
Address:
Warszawa Żwirki i Wigury 101, 02-089 Warszawa
Sector:
Health Care
Industry:
Biotechnology

Description

Molecure is a clinical stage biotechnology company that uses its world leading medicinal chemistry and biology capabilities to discover and develop first-in-class small molecule drug candidates that directly modulate underexplored protein targets and the function of RNA to treat multiple incurable diseases. We have generated a diverse pipeline of seven distinct programs with the support of leading academic life science institutions globally, including Yale University, Rutgers University, the VIB Gent, the University of Michigan, and more recently the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), which has significant expertise in RNA science. Our most advanced in-house drug candidate is OATD-01, a first-in-class dual chitinase inhibitor for the treatment of interstitial lung diseases such as sarcoidosis and idiopathic pulmonary fibrosis that is Phase II ready. Molecure expects to start a Phase II trial in patients with sarcoidosis in 2023.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-05 13:28
Regulatory News Service
Komunikat KDPW w sprawie rejestracji akcji serii J - Content (PL)
Polish 551 bytes
2025-07-03 21:19
Regulatory News Service
Dopuszczenie i wprowadzenie akcji do obrotu na rynku regulowanym GPW - Content …
Polish 927 bytes
2025-07-02 20:21
Share Issue/Capital Change
Warunkowa rejestracja akcji serii J w Krajowym Depozycie Papierów Wartościowych…
Polish 1.2 KB
2025-06-30 19:26
Regulatory News Service
Życiorysy członków organów Molecure SA
Polish 48.5 KB
2025-06-30 19:26
Board/Management Change
Informacja w sprawie powołania członków organów Spółki na nową kadencję - Conte…
Polish 1.5 KB
2025-06-24 21:14
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 2.0 KB
2025-06-24 20:50
Declaration of Voting Results & Voting Rights Announcements
Uchwały podjęte przez ZWZ Molecure 24.06.2025
Polish 480.6 KB
2025-06-24 20:50
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie w dniu 24 czerwca 202…
Polish 1.2 KB
2025-06-05 15:34
Inside Information Statement
Przyjęcie regulaminu oraz podjęcie uchwały w sprawie przeprowadzenia zwolnienia…
Polish 1.6 KB
2025-06-03 22:25
Declaration of Voting Results & Voting Rights Announcements
Projekty uchwał po aktualizacji
Polish 457.9 KB
2025-06-03 22:25
General Meeting Notice
Wniosek akcjonariusza
Polish 278.9 KB
2025-06-03 22:25
General Meeting Notice
Zmiana do porządku obrad oraz zgłoszenie projektu uchwały w ramach sprawy wprow…
Polish 4.8 KB
2025-05-29 23:21
AGM Report
Sprawozdanie Rady Nadzorczej
Polish 243.1 KB
2025-05-29 23:21
Declaration of Voting Results & Voting Rights Announcements
Projekty Uchwał na ZWZ Molecure S.A.
Polish 413.3 KB
2025-05-29 23:21
Remuneration Report
Sprawozdanie o wynagrodzeniach
Polish 245.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC